Peptides Factory Direct Order research peptides
Home / Veterinary / Horses / CJC-1295
Horses research peptide

CJC-1295 in Horses Research

CJC-1295 (with or without DAC) studied in equine research models. A GHRH analog studied for growth-hormone-release research, with and without DAC.

Veterinary research use only. These compounds are sold strictly for laboratory and veterinary research. They are not approved by the FDA for veterinary use, are not for administration to any animal, are not for food-producing animals or the food supply, and nothing here is veterinary medical advice. Most peptide evidence derives from rodent models; species-specific data is limited and under research.

What is CJC-1295?

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

CJC-1295 in equine research

In equine veterinary research, CJC-1295 is studied as a model compound for growth-hormone release research. The horse is one of the most-studied large-animal models in connective-tissue and musculoskeletal research because equine tendon and ligament injuries are common and slow to resolve. Peptides associated with angiogenesis and tissue repair, such as BPC-157 and TB-500 (Thymosin Beta-4), appear frequently in equine-model research literature for exactly this reason.

CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Sourcing, purity & COA for Horses CJC-1295 research

Every lot supplied for Horses CJC-1295 research is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC. A Certificate of Analysis is available on request and ties each vial to a tracked lot. We ship nationwide to veterinary and university research programs with cold-chain handling where appropriate. Publicly verifiable third-party documentation is the trust standard for serious veterinary research material.

Order CJC-1295 for equine research

2 mg vial5 mg vial
See pricing & bundles

Frequently asked questions

Is CJC-1295 studied in equine research?

CJC-1295 appears in equine research models as a model compound (A GHRH analog studied for growth-hormone-release research, with and without DAC.). It is research-use-only and not for administration to horses.

Is CJC-1295 approved for horses?

No. CJC-1295 is not approved by the FDA for veterinary use and is supplied strictly for laboratory and veterinary research, not for administration to any animal.

What sizes of CJC-1295 are available?

CJC-1295 ships as lyophilized research vials (2 mg vial, 5 mg vial), third-party tested with a COA on request.

Can veterinary researchers order CJC-1295 B2B?

Yes - we supply qualified veterinary researchers and facilities B2B and via the research portal.

What is the difference between CJC-1295 with and without DAC?

DAC binds albumin for a long half-life (fewer administrations in research); no-DAC is short-acting and produces sharper GH pulses. Both are research-use-only.

What is CJC-1295 commonly paired with?

In research it is most often studied with Ipamorelin, a GHRP, for synergistic growth-hormone release.

All horses research peptides · CJC-1295 overview

External references: FDA Center for Veterinary Medicine · Peptide (Wikipedia)

CJC-1295 for equine research is research-use-only and not for administration to any animal. Not FDA approved. Not veterinary medical advice.